LivaNova PLC (LIVN) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

24/25

Growth 5 Margin 5 Expansion 5 Platform 4 Financial 5

latest quarter score

Earnings Reports

24
LivaNova (LIVN) Q2 2026: Oxygenator Market Share Jumps to 40% as Capacity Expansion Accelerates
August 05, 2026
22
Livanova (LIVN) Q1 2026: Cardiopulmonary Output to Rise 60% by 2030 as Market Share Jumps
May 06, 2026
23
LIVN Q4 2025: Cardiopulmonary Upgrades Drive 13% Segment Growth as Epilepsy Access Expands
February 25, 2026
21
Livanova (LIVN) Q3 2025: Cardiopulmonary Revenue Jumps 16% as Essence Penetration Accelerates
November 05, 2025
22
LivaNova (LIVN) Q2 2025: Cardiopulmonary Revenue Surges 13% as Essence Upgrade Drives Multi-Year Growth
August 06, 2025
25
LivaNova (LIVN) Q1 2025: Cardiopulmonary Revenue Up 15% as Essence Rollout and Osprey Data Drive Guidance Lift
July 07, 2025

Browse all companies